2021 annual financial data
ANI Pharmaceuticals 2021 Operating margin
Direct answer
Operating margin was -18.41%.
Operating income was -39,793,000 USD and net income was -42,603,000 USD.
Operating cash flow was 3,322,000 USD.
Get free ANI Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 216,136,000 USD
- Operating income
- -39,793,000 USD
- Net income
- -42,603,000 USD
- Operating cash flow
- 3,322,000 USD